Orphan Drugs Market Report

Global and Region Orphan Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：165
  • REPORT CODE：GMM908161
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Orphan Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Orphan Drugsmarket, defines the market attractiveness level of Orphan Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Orphan Drugs industry, describes the types of Orphan Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Orphan Drugs market and the development prospects and opportunities of Orphan Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Orphan Drugs market in Chapter 13.

    By Player:

    • Bayer

    • Merck

    • Eisai

    • Pfizer

    • Shire

    • Celgene

    • Alexion Pharmaceuticals

    • Daiichi Sankyo

    • Amgen

    • Novo Nordisk

    • AstraZeneca

    • Sanofi

    • Novartis

    • Bristol-Myers Squibb

    • GlaxoSmithKline

    • Johnson & Johnson

    • Eli Lilly

    • Roche

    • Biogen

    By Type:

    • Oncology

    • Gastrointestinal

    • Pulmonary

    • Neurology

    • Hematology

    • Cardio-vascular

    • Metabolic disorders

    • Endocrinology

    • Infectious diseases

    • Others

    By End-User:

    • Hospital Pharmacies

    • Speciality Pharmacies

    • Retail pharmacies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Orphan Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Orphan Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Orphan Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Orphan Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Orphan Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Orphan Drugs Consumption (2017-2022)

    • 7.2 United States Orphan Drugs Consumption (2017-2022)

    • 7.3 Europe Orphan Drugs Consumption (2017-2022)

    • 7.4 China Orphan Drugs Consumption (2017-2022)

    • 7.5 Japan Orphan Drugs Consumption (2017-2022)

    • 7.6 India Orphan Drugs Consumption (2017-2022)

    • 7.7 South Korea Orphan Drugs Consumption (2017-2022)

    8 Region and Country-wise Orphan Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Orphan Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Orphan Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Orphan Drugs Consumption Forecast (2022-2028)

    • 8.4 China Orphan Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Orphan Drugs Consumption Forecast (2022-2028)

    • 8.6 India Orphan Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Orphan Drugs Consumption Forecast (2022-2028)

    9 Global Orphan Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Orphan Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gastrointestinal Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Pulmonary Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Neurology Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Hematology Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Cardio-vascular Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Metabolic disorders Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Endocrinology Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Infectious diseases Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Orphan Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Orphan Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Orphan Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Pulmonary Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Neurology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Hematology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Cardio-vascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Metabolic disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Infectious diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Orphan Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Orphan Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Orphan Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Orphan Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Orphan Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Orphan Drugs Market Competitive Analysis

    • 14.1 Bayer

      • 14.1.1 Bayer Company Details

      • 14.1.2 Bayer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bayer Orphan Drugs Product and Service

    • 14.2 Merck

      • 14.2.1 Merck Company Details

      • 14.2.2 Merck Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Orphan Drugs Product and Service

    • 14.3 Eisai

      • 14.3.1 Eisai Company Details

      • 14.3.2 Eisai Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eisai Orphan Drugs Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Orphan Drugs Product and Service

    • 14.5 Shire

      • 14.5.1 Shire Company Details

      • 14.5.2 Shire Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Shire Orphan Drugs Product and Service

    • 14.6 Celgene

      • 14.6.1 Celgene Company Details

      • 14.6.2 Celgene Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Celgene Orphan Drugs Product and Service

    • 14.7 Alexion Pharmaceuticals

      • 14.7.1 Alexion Pharmaceuticals Company Details

      • 14.7.2 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Alexion Pharmaceuticals Orphan Drugs Product and Service

    • 14.8 Daiichi Sankyo

      • 14.8.1 Daiichi Sankyo Company Details

      • 14.8.2 Daiichi Sankyo Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Daiichi Sankyo Orphan Drugs Product and Service

    • 14.9 Amgen

      • 14.9.1 Amgen Company Details

      • 14.9.2 Amgen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Amgen Orphan Drugs Product and Service

    • 14.10 Novo Nordisk

      • 14.10.1 Novo Nordisk Company Details

      • 14.10.2 Novo Nordisk Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novo Nordisk Orphan Drugs Product and Service

    • 14.11 AstraZeneca

      • 14.11.1 AstraZeneca Company Details

      • 14.11.2 AstraZeneca Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AstraZeneca Orphan Drugs Product and Service

    • 14.12 Sanofi

      • 14.12.1 Sanofi Company Details

      • 14.12.2 Sanofi Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Sanofi Orphan Drugs Product and Service

    • 14.13 Novartis

      • 14.13.1 Novartis Company Details

      • 14.13.2 Novartis Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Novartis Orphan Drugs Product and Service

    • 14.14 Bristol-Myers Squibb

      • 14.14.1 Bristol-Myers Squibb Company Details

      • 14.14.2 Bristol-Myers Squibb Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Bristol-Myers Squibb Orphan Drugs Product and Service

    • 14.15 GlaxoSmithKline

      • 14.15.1 GlaxoSmithKline Company Details

      • 14.15.2 GlaxoSmithKline Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 GlaxoSmithKline Orphan Drugs Product and Service

    • 14.16 Johnson & Johnson

      • 14.16.1 Johnson & Johnson Company Details

      • 14.16.2 Johnson & Johnson Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Johnson & Johnson Orphan Drugs Product and Service

    • 14.17 Eli Lilly

      • 14.17.1 Eli Lilly Company Details

      • 14.17.2 Eli Lilly Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Eli Lilly Orphan Drugs Product and Service

    • 14.18 Roche

      • 14.18.1 Roche Company Details

      • 14.18.2 Roche Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Roche Orphan Drugs Product and Service

    • 14.19 Biogen

      • 14.19.1 Biogen Company Details

      • 14.19.2 Biogen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Biogen Orphan Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Orphan Drugs

    • Figure Orphan Drugs Picture

    • Table Global Orphan Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orphan Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orphan Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Orphan Drugs Consumption by Country (2017-2022)

    • Figure United States Orphan Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Orphan Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Orphan Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Orphan Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Orphan Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Orphan Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Orphan Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Orphan Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary Consumption and Growth Rate (2017-2022)

    • Figure Global Neurology Consumption and Growth Rate (2017-2022)

    • Figure Global Hematology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardio-vascular Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Endocrinology Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonary Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hematology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardio-vascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolic disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Orphan Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Orphan Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Orphan Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Orphan Drugs Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Orphan Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Orphan Drugs Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Orphan Drugs Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Orphan Drugs Product and Service

    • Table Alexion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alexion Pharmaceuticals Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Pharmaceuticals Orphan Drugs Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Orphan Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Orphan Drugs Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Orphan Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Orphan Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Orphan Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Orphan Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Orphan Drugs Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Orphan Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Orphan Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Orphan Drugs Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Orphan Drugs Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Orphan Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Orphan Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US